All sites C00-96,D32-33,D42-43,D45-47,D76 345 85.2 6.4 3.8 0.6 4.0
Mouth, pharynx C00-14 10 91.8 - 4.1 - 4.1
  Lip C00 0 100.0 - - - -
  Tongue C02 2 75.0 - 8.3 - 16.7
  Mouth, other C03-06 3 100.0 - - - -
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 3 93.8 - 6.3 - -
Digestive organs C15-26 80 85.7 1.8 5.0 1.0 6.5
  Oesophagus C15 4 81.0 - 4.8 9.5 4.8
  Stomach C16 11 94.6 1.8 - 1.8 1.8
  Small intestine C17 2 88.9 11.1 - - -
  Colon C18 22 98.1 - 0.9 - 0.9
  Rectum, rectosigmoid C19-20 16 96.2 - 2.6 - 1.3
  Anus C21 0 100.0 - - - -
  Liver C22 8 82.1 2.6 - 2.6 12.8
  Gallbladder, bile ducts C23-24 3 80.0 6.7 13.3 - -
  Pancreas C25 13 55.4 3.1 18.5 - 23.1
  Other digestive organs C26 1 16.7 16.7 33.3 - 33.3
Respiratory organs C30-39 46 49.6 33.9 12.2 - 4.3
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 3 92.3 - 7.7 - -
  Lung, trachea C33-34 43 47.2 36.4 12.1 - 4.2
  Mediastinum, pleura C38 0 - - - - 100.0
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 13 100.0 - - - -
Skin, non-melanoma C44 9 97.9 2.1 - - -
Mesothelioma C45 1 100.0 - - - -
Autonomic nervous system C47 1 100.0 - - - -
Soft tissues C48-49 1 100.0 - - - -
Breast C50 0 100.0 - - - -
Male genital organs C60-63 101 98.4 - - 0.8 0.8
  Prostate C61 99 98.4 - - 0.8 0.8
  Testis C62 2 100.0 - - - -
  Other male genital C60,C63 1 100.0 - - - -
Urinary organs C64-68 35 89.6 2.3 3.5 - 4.6
  Kidney C64 12 85.0 - 6.7 - 8.3
  Bladder and urinary tract2 C65-68 23 92.0 3.5 1.8 - 2.7
Eye C69 0 50.0 - 50.0 - -
Brain, central nervous system C70-72,D32-33,D42-43 7 88.6 - 11.4 - -
Thyroid gland C73 2 90.9 - 9.1 - -
Other endocrine glands C74-75 - - - - - -
Illdefined or unknown C76,C80 7 45.7 11.4 11.4 5.7 25.7
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 31 83.2 10.3 - - 6.5
  Hodgkin lymphoma C81 1 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 15 98.6 - - - 1.4
  Malignant immunoproliferative diseases C88 - - - - - -
  Myeloma and other plasma cell tumors C90 2 91.7 8.3 - - -
  Leukaemia C91-95 9 70.5 20.5 - - 9.1
  Myelodysplastic syndromes D46 2 10.0 50.0 - - 40.0
  Myeloproliferaitive neoplasms D45,D47 2 77.8 11.1 - - 11.1
Not included above
  Basal cell carcinoma of the skin 78 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.